XML 57 R44.htm IDEA: XBRL DOCUMENT v3.24.1
Note 18 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
   

Year ended December 31,

 
   

2023

   

2022

 

Domestic

  $ (3,527 )   $ (4,661 )

Foreign

    2,594       3,115  

Total

  $ (933 )   $ (1,546 )
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
   

Year ended December 31,

 
   

2023

   

2022

 

Current:

               

Federal

  $ 0     $ 0  

State

    10       3  

Foreign

    599       616  

Total current income tax expense

    609       619  
                 

Deferred:

               

Federal

    0       0  

State

    0       0  

Foreign

    54       329  

Total deferred income tax expense

    54       329  

Income tax expense, net

  $ 663     $ 948  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
   

Year ended December 31,

 
   

2023

   

2022

 

Federal tax expense at the statutory rate

  $ (196 )   $ (325 )

Current year permanent differences

    35       167  

State income taxes, net of federal tax impact

    (72 )     (102 )

Effect of tax rates of foreign subsidiary

    235       282  

Return to provision

    (35 )     (132 )

Change in valuation allowance

    469       876  
Research & experimental tax credit expiration     227       182  

Income tax expense (benefit), net

  $ 663     $ 948  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   

Year ended December 31,

 
   

2023

   

2022

 

Deferred tax assets:

               

Compensation and benefit accruals

  $ 525     $ 423  

Inventory valuation

    848       889  

Federal and state net operating loss carryforwards

    34,980       35,265  

Deferred revenue

    848       84  

Interest limitation carryover

    586       456  

Defined benefit pension plan

    305       449  

Lease liabilities

    673       865  

Foreign deferred revenue and other provisions

    2,657       2,367  
Capitalized research and experimental costs     201       99  

Other

    381       599  

Total

    42,004       41,496  

Domestic valuation allowance

    (38,222

)

    (38,028

)

Total deferred tax assets

    3,782       3,468  
                 

Deferred tax liabilities:

               

Prepaid and other assets

    (589

)

    (396

)

Right-of-use assets, net

    (536

)

    (705

)

Total deferred tax liabilities

    (1,125

)

    (1,101

)

Net deferred tax asset

  $ 2,657     $ 2,367